Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Azura Rozila Ahmad

1PUBLICATIONS

15CO-AUTHORS

Molecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Mar 27, 2023

Randomized Trial of Tepotinib Plus Gefitinib versus Chemotherapy in EGFR-Mutant NSCLC with EGFR Inhibitor Resistance Due to MET Amplification: INSIGHT Final Analysis.

Chong Kin Liam, Azura Rozila Ahmad, Te-Chun Hsia

Pageof 1

Frequent Collaborators

1 joint publications

Chong Kin Liam

1 joint publications

Te-Chun Hsia

1 joint publications

Jianying Zhou

1 joint publications

Dong-Wan Kim

1 joint publications

Ross Andrew Soo

1 joint publications

Ying Cheng

1 joint publications

Shun Lu

1 joint publications

Sang Won Shin

1 joint publications

James Chih-Hsin Yang

1 joint publications

Yiping Zhang

Frequent Collaborators

1 joint publications

Chong Kin Liam

1 joint publications

Te-Chun Hsia

1 joint publications

Jianying Zhou

1 joint publications

Dong-Wan Kim

Top Related Videos

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Published on : Aug 11, 2017

See more related videos

Top Related Videos

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Published on : Aug 11, 2017

See more related videos